This is great news, thanks @BuffettWarren, I've recently invested in a few more companies than I usually would and this timeline went through to the keeper, thanks for your help. I like the prospects for EBR and think it will be noticed more over the course of this year and obviously go a rocket in the leadup to submission to FDA. The wait after submission during the review period usually sees even more interesting increases so I like ERB's timeline a lot. All shareholders now could be expecting multiples in the coming year
This is great news, thanks @BuffettWarren, I've recently...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.010(0.96%) |
Mkt cap ! $331.2M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.08 | $1.00 | $155.7K | 149.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12000 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 901 | 1 |
View Market Depth
| Last trade - 15.09pm 27/06/2024 (20 minute delay) ? |
| EBR (ASX) Chart |